We are live on ! Find out more
STLNW

Starling Oncology Warrant

12 hedge funds and large institutions have $818K invested in Starling Oncology Warrant in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

319% more capital invested

Capital invested by funds: $195K → $818K (+$623K)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

9% more funds holding

Funds holding: 11 → 12 (+1)

4.28% less ownership

Funds ownership: 4.28% → 0% (-4.3%)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
+$9K

STLNW Hedge Fund Activity: Q3 2025 in Review

12 of the 7,645 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Warrant (STLNW) for Q3 2025, worth a combined $818K — up 319% from $195K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new STLNW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Oasis Management Company, opening a new position worth an estimated $11.4K. The largest seller was UBS Group, exiting entirely with an estimated $187 sold.

  • 12 institutional investors held Starling Oncology Warrant (STLNW) as of Q3 2025, up from 11 in Q2 2025.
  • Funds reported $818K of Starling Oncology Warrant stock for Q3 2025, up 319% quarter-over-quarter.
  • 2 funds opened new Starling Oncology Warrant positions in Q3 2025 and 1 closed out, a net change of +1 holder.
  • The largest Starling Oncology Warrant buyer in Q3 2025 was Oasis Management Company, an estimated $11.4K added.
  • The largest Starling Oncology Warrant seller in Q3 2025 was UBS Group, an estimated $187 sold.

Based on aggregated 13F filings for Q3 2025.